Here are some other studies in our collection.
Study 25 – The Genes, Environment, and Development Initiative (GEDI)
Investigator: William G. Iacono Status: Available at dbGaP dbGaP Accession ID: phs000620.v1.p1 Abstract: We propose using established longitudinal studies of 7300 parents and twin children to investigate how gene-environment interplay influences the development of substance abuse (SA). Our focus is on children assessed repeatedly, beginning in pre-adolescence at age 11 and then again at approximately ages 14, 17, 20, 24,...
Study 26 – The Genes, Environment, and Development Initiative (GEDI)
Investigators: E. Jane Costello, Ph.D. (Duke University), Lindon Eaves, Ph.D. (Virginia Commonwealth University) Status: Available at dbGaP dbGaP Accession ID: phs000852.v1.p1 Abstract: This application "A developmental model of gene-environment interplay in SUDs" (substance use disorders), responds to NIDA RFA-DA-70-012. It brings together investigators with existing data that meet the requirements of the U01: Duke University (sample N-1400) and Virginia Commonwealth...
Study 32 – Achieving Cannabis Cessation-Evaluation of N-Acetylcysteine (ACCENT); CTN-0053
Investigator: Kevin M. Gray, M.D. (Medical University of South Carolina) Release Date: TBA View Study in Clinical Trials Network Site Abstract: This study is a 12-week, double-blind, randomized, placebo controlled trial of N-acetylcysteine (NAC) 1200mg twice daily, added to contingency management (CM), for the treatment of cannabis use among treatment-seeking cannabis-dependent adults (18-60). Approximately 300 participants will be randomized into...
Study 33 – Genome-wide Association Study of HIV-1 Host Genetics Among Injection Drug Users
Investigator: Eric Johnson, Ph.D. (RTI International) Status: Available at dbGaP dbGaP Accession ID: phs000454.v2.p2 Abstract: Vancouver Injection Drug User Study (VIDUS) The overaching goal of this project remains to identify and characterize genetic deteminants of HIV-1 susceptibility and resistance in a large sample of injection drug users (IDUs). We plan to expand beyond our initial GWAS and replication of HIV...
Study 34 – Attention Deficit-Hyperactivity Disorder (ADHD)
Investigators: Robert K. Moyzis, Ph.D., Deborah L. Grady, Ph.D. (University of California, Irvine) Release Date: TBA Abstract: Project 1) Clinical Trials Probands and Families Cell line establishment funded by NIMH MH060660 (Robert Moyzis, PI) and DOE DE-FG03-97ER62485 (Robert Moyzis, PI), University of California, Irvine School of Medicine Molecular Genetic Epidemiology Study of ADHD/DRD4 (original 2000 abstract NIMH MH60660) Utilizing the...
Study 36 – Genetic Dissection in Pedigrees of Substance Use and Mood Disorders Comorbidity
Investigators: Henriette Raventós, Nelson B. Freimer, and Victor Reus Release Date: TBA Abstract: Substance use disorders (SUDs) and mood disorders (MDs) are highly prevalent disorders that, on their own, result in devastating outcomes and burden on individuals, their families, and society as a whole. Their comorbidity, however, complicates treatment and aggravates outcomes. While both types of disorders are heritable, the...
Study 37 – Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder; CTN-0068
Investigator: Madhukar Trivedi Release Date: TBA View Study in Clinical Trials Network Site Study Objective: The primary objective of this study is to evaluate the efficacy of extended-release naltrexone plus bupropion as a combination pharmacotherapy for methamphetamine use disorder. Secondary objectives include assessing the safety of naltrexone plus bupropion and determining the efficacy of the combination pharmacotherapy on other substance...
Study 38 – Adolescent Brain Cognitive Development (ABCD) Study
UNDER CONSTRUCTION Investigator: Status: Data Available at NDA Files No instrument available
Study 42 – Genetics Analysis of Substance Use Disorder Using the Indiana Biobank Data
Investigators: Dongbing Lai, Ph.D., Tae-Hwi Linus Schwantes-An, Ph.D., & Howard J. Edenberg, Ph.D. Release Date: TBA Objective: The goal of this study is to identify genes related to substance use disorders, both individually (e.g. opioid, cannabis, cocaine, etc.) as well as those related to substance use disorders in general. The study participants were selected from the Indiana Biobank, which is...
Study 43 – Pediatric Imaging, Neurocognition, and Genetics (PING)
Investigators: Sarah Murray, Terry Jernigan Release Date: TBA Objective: This exciting new study has unique aims and unprecedented scope. The goal is to understand the genetic basis of individual differences in brain structure and connectivity, cognition, and personality. Since it is known that structural and functional connectivity in the brain undergoes continuous remodeling during childhood, the investigators will study 1400...